A
Andrew Farlow
Researcher at University of Oxford
Publications - 22
Citations - 9159
Andrew Farlow is an academic researcher from University of Oxford. The author has contributed to research in topics: Dengue vaccine & Dengue fever. The author has an hindex of 13, co-authored 20 publications receiving 7520 citations.
Papers
More filters
Journal ArticleDOI
The global distribution and burden of dengue
Samir Bhatt,Peter W. Gething,Oliver J. Brady,Jane P. Messina,Andrew Farlow,Catherine L. Moyes,John M. Drake,John M. Drake,John S. Brownstein,Anne G. Hoen,Osman Sankoh,Osman Sankoh,Monica F. Myers,Dylan B. George,Thomas Jaenisch,G. R. William Wint,Cameron P. Simmons,Thomas W. Scott,Thomas W. Scott,Jeremy Farrar,Jeremy Farrar,Simon I. Hay,Simon I. Hay +22 more
TL;DR: These new risk maps and infection estimates provide novel insights into the global, regional and national public health burden imposed by dengue and will help to guide improvements in disease control strategies using vaccine, drug and vector control methods, and in their economic evaluation.
Journal ArticleDOI
Refining the global spatial limits of dengue virus transmission by evidence-based consensus
Oliver J. Brady,Peter W. Gething,Samir Bhatt,Jane P. Messina,John S. Brownstein,Anne G. Hoen,Catherine L. Moyes,Andrew Farlow,Thomas W. Scott,Thomas W. Scott,Simon I. Hay,Simon I. Hay +11 more
TL;DR: A contemporary global map of national-level dengue status is generated that assigns a relative measure of certainty and identifies gaps in the available evidence and provides a preliminary estimate of population at risk with an upper bound of 3.97 billion people.
Journal ArticleDOI
An economic evaluation of vector control in the age of a dengue vaccine
Christopher Fitzpatrick,Alexander Haines,Alexander Haines,Mathieu Bangert,Andrew Farlow,Janet Hemingway,Raman Velayudhan +6 more
TL;DR: Sustained vector control could be highly cost-effective even with less effective technologies and in the presence of a highly targeted and low cost immunization strategy using a medium-efficacy vaccine.
Journal ArticleDOI
Molecules from nature: Reconciling biodiversity conservation and global healthcare imperatives for sustainable use of medicinal plants and fungi
Melanie-Jayne R. Howes,Melanie-Jayne R. Howes,Cassandra L. Quave,Jérôme Collemare,Evangelos C. Tatsis,Danielle Twilley,Ermias Lulekal,Andrew Farlow,Liping Li,María‐Elena Cazar,Danna J. Leaman,Thomas A.K. Prescott,William Milliken,Cathie Martin,Marco Nuno De Canha,Namrita Lall,Namrita Lall,Namrita Lall,Haining Qin,Barnaby E. Walker,Carlos A. Vásquez-Londoño,Bob Allkin,Malin C. Rivers,Monique S. J. Simmonds,Elizabeth Bell,Alex Battison,Juri Felix,Félix Forest,Christine Leon,China Williams,Eimear Nic Lughadha +30 more
TL;DR: Current and emerging scientific approaches are presented, to uncover and preserve nature-based health solutions for the future, through harmonization with biodiversity conservation strategies.
Journal ArticleDOI
Dengue expansion in Africa-not recognized or not happening?
Thomas Jaenisch,Thomas Junghanss,Bridget Wills,Oliver J. Brady,Isabella Eckerle,Andrew Farlow,Simon I. Hay,Philip J. McCall,Jane P. Messina,Victor Ofula,Amadou A. Sall,Anavaj Sakuntabhai,Raman Velayudhan,G. R. William Wint,Herve Zeller,Harold S. Margolis,Osman Sankoh +16 more
TL;DR: This expansion is essential before control and prevention of dengue are implemented and it is essential to address this expansion, experts say.